Company news
Bluenergies Ltd. news in 2012
Bluenergies Ltd.'s news releases, calls and decks from 2012, newest first.
BELLUS Health Reports Results for Third Quarter Ended September 30, 2012, and Provides an Update on KIACTA(TM) Phase III Confirmatory Study
November 8, 2012
BELLUS Health to Present at BioContact in Québec City
October 1, 2012
BELLUS Health Announces Partnership for the Development of BLU8499
September 4, 2012
BELLUS Health Reports Results for Second Quarter Ended June 30, 2012
August 8, 2012
BELLUS Health Receives Milestone Payment from Advanced Orthomolecular Research
June 21, 2012
Bellus Health to Present at Bloom Burton & Co. Healthcare Investor Conference
June 6, 2012
Bellus Health to Present at BioFinance 2012
May 25, 2012
Bellus Health and Pharmascience Announce Closing of $17.25M Transaction
May 25, 2012
BELLUS Health Securityholders Vote in Favour Of $17.25 Million Strategic Transaction with Pharmascience
May 15, 2012
BELLUS Health announces update on the Phase III trial for KIACTA(tm) in AA amyloidosis presented at the XIII International Symposium on Amyloidosis
May 10, 2012
BELLUS Health Announces Share Consolidation and Record Date for Annual and Special Meeting of Securityholders
April 19, 2012
BELLUS Health announces a $17 million strategic partnership and financing with Pharmascience Inc.
April 5, 2012
BELLUS Health reports results for year ended December 31, 2011, and provides update on KIACTA(tm) phase 3 confirmatory study
February 22, 2012